[99mTc-MAB bone marrow scintigraphy and probe-guided biopsy in aplastic anemia].
The diagnosis of systemic haematological disorders is often confirmed by bone marrow biopsy which is usually performed "blind". False-negative results may be obtained because this method is restricted to a small part of the blood-forming organ. Bone marrow scintigraphy has the potential of detecting the distribution of active haematopoietic bone marrow and to localize infiltrative lesions. This case report of a patient with pancytopenia demonstrates that the diagnosis of aplastic anaemia can be confirmed by bone marrow scintigraphy in combination with probe-guided bone marrow biopsy.
Jonas
M
M
Klinik und Poliklinik für Nuklearmedizin, Westfälische Wilhelms-Universität Münster, FRG.
Sciuk
J
J
Dreyling
M
M
D000368:Aged; D000741:Anemia, Aplastic / Q000000981:diagnostic imaging* / Q000473:pathology; D001707:Biopsy, Needle; D001853:Bone Marrow / Q000000981:diagnostic imaging* / Q000473:pathology; D001856:Bone Marrow Examination / Q000379:methods; D005260:Female; D006801:Humans; D016719:Radioimmunodetection; D013667:Technetium
D013667:Technetium
99mTc-MAk-Knochenmarkszintigraphie und sondengezielte Punktion bei aplastischer Anämie.